a Therapeutics(COYA) - 2024 Q1 - Quarterly Report
a Therapeutics(COYA)2024-05-09 20:26(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR | --- | --- | |-----------------------------------------------------------------------------------------------------------|------------------------------------------| | Commission File Number: \nCoya Therapeutics, (Exact Name of Registrant as Specified | 001-41583 \n Inc. in its Charter) | | Delaware | 85-4017781 | | (State or other jurisdiction of incorporati ...